The complexity of cancer care continues to increase, with new drugs approved and biomarkers discovered each year. Oncologists need decision support with access to up-to-date, evidence-based information to provide the best care for patients. This combined with rising healthcare costs associated with expensive cancer therapies has led to the rapid uptake in use of oncology clinical pathways, though it is cumbersome to maintain and share the pathways.
Computable oncology pathways based on nationally accepted guidelines, and the HL7 FHIR Clinical Guidelines and mCODE standards provide evidence based treatment recommendations to the oncologist.
An Oncology Clinical Pathway (OCP): detailed decision tree protocol for selection of treatment options by oncologists, primarily focused on anticancer drug regimens for specific patient populations, including type, stage, and molecular subtype of disease.